Viewing Study NCT01221259


Ignite Creation Date: 2025-12-24 @ 2:50 PM
Ignite Modification Date: 2026-02-22 @ 6:44 PM
Study NCT ID: NCT01221259
Status: COMPLETED
Last Update Posted: 2013-05-22
First Post: 2010-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy Subjects
Sponsor: Eisai Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module